scholarly journals Successful treatment with low-dose decitabine in acute myelogenous leukemia in elderly patients over 80 years old: Five case reports

2013 ◽  
Vol 5 (4) ◽  
pp. 1321-1324 ◽  
Author(s):  
JIE LIN ◽  
HONGLI ZHU ◽  
SUXIA LI ◽  
HUI FAN ◽  
XUECHUN LU ◽  
...  
Keyword(s):  
Elderly Patients ◽  
Successful Treatment ◽  
Acute Myelogenous Leukemia ◽  
Low Dose ◽  
Case Reports ◽  
Myelogenous Leukemia ◽  
Acute Myelogenous

scholarly journals Bacillus cereus Typhlitis in a Patient with Acute Myelogenous Leukemia: A Case Report and Review of the Literature

2018 ◽  
Vol 2018 ◽  
pp. 1-4
Author(s):  
James D. Denham ◽  
Sowmya Nanjappa ◽  
John N. Greene
Keyword(s):  
Bacillus Cereus ◽  
Acute Myelogenous Leukemia ◽  
English Language ◽  
Neutropenic Patient ◽  
Hematologic Malignancy ◽  
Case Reports ◽  
Clinical Manifestations ◽  
Case Series ◽  
Myelogenous Leukemia ◽  
Acute Myelogenous

Bacillus cereus is a Gram-positive rod that is now recognized as a rare cause of frank disease in the neutropenic hematologic malignancy patient. Because this pathogen is rarely isolated in clinical specimens, no large studies exist to guide the management of these acutely ill patients. Individual case reports and case series exist in the literature describing various clinical manifestations of B. cereus in the neutropenic patient including bacteremia/septicemia, pneumonia, meningitis/encephalitis, hepatic abscesses, and gastritis. In this report, we describe a case of typhlitis caused by B. cereus in a 74-year-old female with recently diagnosed acute myelogenous leukemia (AML), and we summarize the available English language literature to draw tentative conclusions regarding the clinical manifestations of this organism.

Successful Treatment with Imatinib Mesylate in a Case of Minor BCR-ABL-Positive Acute Myelogenous Leukemia

2005 ◽  
Vol 81 (3) ◽  
pp. 242-245 ◽  
Author(s):  
Katsuro Ito ◽  
Kazunori Tominaga ◽  
Toshiya Suzuki ◽  
Itsuro Jinnai ◽  
Masami Bessho
Keyword(s):  
Imatinib Mesylate ◽  
Successful Treatment ◽  
Acute Myelogenous Leukemia ◽  
Myelogenous Leukemia ◽  
Acute Myelogenous

scholarly journals Phase II study of low-dose continuous infusion homoharringtonine in refractory acute myelogenous leukemia

Cancer ◽  
1989 ◽  
Vol 63 (5) ◽  
pp. 813-817 ◽  
Author(s):  
Hagop M. Kantarjian ◽  
Michael J. Keating ◽  
Ronald S. Walters ◽  
Charles A. Koller ◽  
Kenneth B. McCredie ◽  
...  
Keyword(s):  
Continuous Infusion ◽  
Phase Ii ◽  
Acute Myelogenous Leukemia ◽  
Low Dose ◽  
Phase Ii Study ◽  
Myelogenous Leukemia ◽  
Acute Myelogenous
Sign in / Sign up

Export Citation Format

Share Document